Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
10,051
Value
$180.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SRPT by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,051$180.6K<0.1%−4,791−32.3%ReducedHolders
Q1 202614,842$323.0K<0.1%+2,342+18.7%AddedHolders
Q4 202512,500$269.0K<0.1%+555+4.6%AddedHolders
Q3 202511,945$230.2K<0.1%−5,950−33.2%ReducedHolders
Q2 202517,895$306.0K<0.1%−1,426−7.4%ReducedHolders
Q1 202519,321$1.23M<0.1%+608+3.2%AddedHolders
Q4 202418,713$2.28M<0.1%+571+3.1%AddedHolders
Q3 202418,142$2.27M<0.1%−404−2.2%ReducedHolders
Q2 202418,546$2.93M<0.1%+7,106+62.1%AddedHolders
Q1 202411,440$1.48M<0.1%−288−2.5%ReducedHolders
Q4 202311,728$1.13M<0.1%−882−7.0%ReducedHolders
Q3 202312,610$1.53M<0.1%+72+0.6%AddedHolders
Q2 202312,538$1.44M<0.1%+1,051+9.1%AddedHolders
Q1 202311,487$1.58M<0.1%+93+0.8%AddedHolders
Q4 202211,394$1.48M<0.1%+1,477+14.9%AddedHolders
Q3 20229,917$1.10M<0.1%+54+0.5%AddedHolders
Q2 20229,863$739.0K<0.1%+479+5.1%AddedHolders
Q1 20229,384$733.0K<0.1%+52+0.6%AddedHolders
Q4 20219,332$840.0K<0.1%+772+9.0%AddedHolders
Q3 20218,560$792.0K<0.1%−345−3.9%ReducedHolders
Q2 20218,905$692.0K<0.1%+1,095+14.0%AddedHolders
Q1 20217,810$582.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.